Stem cells and regenerative medicine in lung biology and diseases

Molecular Therapy

Volumn 20, Issue 6, 2012, Pages 1116-1130

  Lau, Allison N ^a,b   Goodwin, Meagan ^c   Kim, Carla F ^a,b   Weiss, Daniel J ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LUNG INJURY; ASTHMA; BRONCHIOLITIS OBLITERANS; CANCER STEM CELL; CELL POPULATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMBRYONIC STEM CELL; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LUNG CANCER; LUNG DISEASE; LUNG DYSPLASIA; LUNG EMPHYSEMA; LUNG FIBROSIS; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NONHUMAN; PLURIPOTENT STEM CELL; PULMONARY HYPERTENSION; REGENERATIVE MEDICINE; REVIEW; SEPSIS; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84862777878     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.37     Document Type: Review

References (230)

1. Orens, JB and Garrity, ER Jr (2009). General overview of lung transplantation and review of organ allocation. Proc Am Thorac Soc 6: 13-19.
2. Macchiarini, P, Jungebluth, P, Go, T, Asnaghi, MA, Rees, LE, Cogan, TA et al.(2008). Clinical transplantation of a tissue-engineered airway. Lancet 372: 2023-2030.
3. Weiss, DJ, Kolls, JK, Ortiz, LA, Panoskaltis-Mortari, A and Prockop, DJ (2008). Stemcells and cell therapy approaches for lung diseases. Conference Report. Proc Am Thorac Soc 5: 637-667.
4. Weiss, DJ, Bertoncello, I, Borok, Z, Kim, C, Panoskaltsis-Mortari, A, Reynolds, S et al. (2011). Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 8: 223-272.
5. Rawlins, EL and Hogan, BL (2006). Epithelial stem cells of the lung: privileged few or opportunities for many? Development 133: 2455-2465. (Pubitemid 44123396)
6. Borthwick, DW, Shahbazian, M, Krantz, QT, Dorin, JR and Randell, SH (2001). Evidence for stem-cell niches in the tracheal epithelium. Am J Respir Cell Mol Biol 24: 662-670. (Pubitemid 32550587)
7. Daniely, Y, Liao, G, Dixon, D, Linnoila, RI, Lori, A, Randell, SH et al. (2004). Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. Am J Physiol, Cell Physiol 287: C171-C181. (Pubitemid 38780165)
8. Schoch, KG, Lori, A, Burns, KA, Eldred, T, Olsen, JC and Randell, SH (2004). A subset of mouse tracheal epithelial basal cells generates large colonies in vitro. Am J Physiol Lung Cell Mol Physiol 286: L631-L642. (Pubitemid 38365045)
9. Rock, JR, Onaitis, MW, Rawlins, EL, Lu, Y, Clark, CP, Xue, Y et al. (2009). Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA 106: 12771-12775.
10. Avril-Delplanque, A, Casal, I, Castillon, N, Hinnrasky, J, Puchelle, E and Péault, B (2005). Aquaporin-3 expression in human fetal airway epithelial progenitor cells. Stem Cells 23: 992-1001. (Pubitemid 41170955)
11. Hong, KU, Reynolds, SD, Watkins, S, Fuchs, E and Stripp, BR (2004). In vivo differentiation potential of tracheal basal cells: evidence for multipotent and unipotent subpopulations. Am J Physiol Lung Cell Mol Physiol 286: L643-L649. (Pubitemid 38365046)
12. Hong, KU, Reynolds, SD, Watkins, S, Fuchs, E and Stripp, BR (2004). Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol164: 577-588. (Pubitemid 38364673)
13. Ghosh, M, Brechbuhl, HM, Smith, RW, Li, B, Hicks, DA, Titchner, T et al. (2011). Context-dependent differentiation of multipotential keratin 14-expressing tracheal basal cells. Am J Respir Cell Mol Biol 45: 403-410.
14. Hegab, AE, Ha, VL, Gilbert, JL, Zhang, KX, Malkoski, SP, Chon, AT et al. (2011). Novel stem/progenitor cell population from murine tracheal submucosal gland ducts with multipotent regenerative potential. Stem Cells 29: 1283-1293.
15. Reynolds, SD, Giangreco, A, Power, JH and Stripp, BR (2000). Neuroepithelial bodies of pulmonary airways serve as a reservoir of progenitor cells capable of epithelial regeneration. Am J Pathol 156: 269-278. (Pubitemid 30644460)
16. Hong, KU, Reynolds, SD, Giangreco, A, Hurley, CM and Stripp, BR (2001). Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol 24: 671-681. (Pubitemid 32550588)
17. Giangreco, A, Reynolds, SD and Stripp, BR (2002). Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol 161: 173-182. (Pubitemid 34760783)
18. Kim, CF, Jackson, EL, Woolfenden, AE, Lawrence, S, Babar, I, Vogel, S et al. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835. (Pubitemid 40806415)
19. Raiser, DM and Kim, CF (2009). Commentary: Sca-1 and Cells of the Lung: A matter of Different Sorts. Stem Cells 27: 606-611.
20. McQualter, JL, Yuen, K, Williams, B and Bertoncello, I (2010). Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc Natl Acad Sci USA 107: 1414-1419.
21. Zacharek, SJ, Fillmore, CM, Lau, AN, Gludish, DW, Chou, A, Ho, JW et al. (2011). Lung stem cell self-renewal relies on BMI1-dependent control of expression at imprinted loci. Cell Stem Cell 9: 272-281.
22. Teisanu, RM, Chen, H, Matsumoto, K, McQualter, JL, Potts, E, Foster, WM et al.(2011). Functional analysis of two distinct bronchiolar progenitors during lung injury and repair. Am J Respir Cell Mol Biol 44: 794-803.
23. Evans, MJ, Johnson, LV, Stephens, RJ and Freeman, G (1976). Renewal of the terminalbronchiolar epithelium in the rat following exposure to NO2 or O3. Lab Invest 35: 246-257.
24. Evans, MJ, Shami, SG, Cabral-Anderson, LJ and Dekker, NP (1986). Role of nonciliated cells in renewal of the bronchial epithelium of rats exposed to NO2. Am J Pathol 123: 126-133. (Pubitemid 16038141)
25. Barth, PJ and Müller, B (1999). Effects of nitrogen dioxide exposure on Clara cell proliferation and morphology. Pathol Res Pract 195: 487-493.
26. Rawlins, EL and Hogan, BL (2008). Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol 295: L231-L234.
27. Rawlins, EL, Okubo, T, Xue, Y, Brass, DM, Auten, RL, Hasegawa, H et al. (2009). The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4: 525-534.
28. Aso, Y, Yoneda, K and Kikkawa, Y (1976). Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest 35: 558-568. (Pubitemid 8031372)
29. Kawamoto, M and Fukuda, Y (1990). Cell proliferation during the process of bleomycin-induced pulmonary fibrosis in rats. Acta Pathol Jpn 40: 227-238. (Pubitemid 20285287)
30. Isakson, BE, Lubman, RL, Seedorf, GJ and Boitano, S (2001). Modulation of pulmonary alveolar type II cell phenotype and communication by extra-cellular matrix and KGF. Am J Physiol Cell Physiol 281: C1291-C1299.
31. Rock, JR, Barkauskas, CE, Cronce, MJ, Xue, Y, Harris, JR, Liang, J et al. (2011). Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA 108: E1475-E1483.
32. Chapman, HA, Li, X, Alexander, JP, Brumwell, A, Lorizio, W, Tan, K et al. (2011). Integrin a6ß4 identifies an adult distal lung epithelial population with regenerative potential in mice. J Clin Invest 121: 2855-2862.
33. Kumar, PA, Hu, Y, Yamamoto, Y, Hoe, NB, Wei, TS, Mu, D et al. (2011). Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell 147: 525-538.
34. Kajstura, J, Rota, M, Hall, SR, Hosoda, T, D'Amario, D, Sanada, F et al. (2011). Evidence for human lung stem cells. N Engl J Med 364: 1795-1806.
35. Lung stem cells: looking beyond the hype (2011). Nat Med 17: 788-789.
36. Rock, JR, Randell, SH and Hogan, BL (2010). Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech 3: 545-556.
37. Murphy, J, Summer, R and Fine, A (2008). Stem cells in airway smooth muscle: state of the art. Proc Am Thorac Soc 5: 11-14.
38. Summer, R, Fitzsimmons, K, Dwyer, D, Murphy, J and Fine, A (2007). Isolation of an adult mouse lung mesenchymal progenitor cell population. Am J Respir Cell Mol Biol 37: 152-159. (Pubitemid 47254998)
39. Hennrick, KT, Keeton, AG, Nanua, S, Kijek, TG, Goldsmith, AM, Sajjan, US et al. (2007). Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med 175: 1158-1164. (Pubitemid 46855457)
40. Lama, VN, Smith, L, Badri, L, Flint, A, Andrei, AC, Murray, S et al. (2007). Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest 117: 989-996. (Pubitemid 46556755)
41. Martin, J, Helm, K, Ruegg, P, Varella-Garcia, M, Burnham, E and Majka, S (2008). Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy 10: 140-151.
42. Jarvinen, L, Badri, L, Wettlaufer, S, Ohtsuka, T, Standiford, TJ, Toews, GB et al. (2008). Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol 181: 4389-4396.
43. Karoubi, G, Cortes-Dericks, L, Breyer, I, Schmid, RA and Dutly, AE (2009). Identification of mesenchymal stromal cells in human lung parenchyma capable of differentiating into aquaporin 5-expressing cells. Lab Invest 89: 1100-1114.
44. Hegab, AE, Kubo, H, Fujino, N, Suzuki, T, He, M, Kato, H et al. (2010). Isolation and characterization of murine multipotent lung stem cells. Stem Cells Dev 19: 523-536.
45. Bentley, JK, Popova, AP, Bozyk, PD, Linn, MJ, Baek, AE, Lei, J et al. (2010). Ovalbumin sensitization and challenge increases the number of lung cells possessing a mesenchymal stromal cell phenotype. Respir Res 11: 127.
46. Jakob, M, Hemeda, H, Janeschik, S, Bootz, F, Rotter, N, Lang, S et al. (2010). Human nasal mucosa contains tissue-resident immunologically responsive mesenchymal stromal cells. Stem Cells Dev 19: 635-644.
47. Ingenito, E, Tsai, L, Murthy, S, Tyagi S, Mazan M and Hoffman, A (2011). Autologous lung-derived mesenchymal stem cell transplantation in experimental emphysema.Stem Cells Dev 20: 1779-1792.
48. Bozyk, PD, Popova, AP, Bentley, JK, Goldsmith, AM, Linn, MJ, Weiss, DJ et al. (2011). Mesenchymal stromal cells from neonatal tracheal aspirates demonstrate a pattern of lung-specific gene expression. Stem Cells Dev 20: 1995-2007.
49. Jun, D, Garat, C, West, J, Thorn, N, Chow, K, Cleaver, T et al. (2011). The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells 29: 725-735.
50. Hoffman, AM, Paxson, JA, Mazan, MR, Davis, AM, Tyagi, S, Murthy, S et al. (2011). Lung-derived mesenchymal stromal cell post-transplantation survival, persistence, paracrine expression, and repair of elastase-injured lung. Stem Cells Dev 20: 1779-1792.
51. Badri, L, Murray, S, Liu, LX, Walker, NM, Flint, A, Wadhwa, A et al. (2011). Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 183: 1062-1070.
52. Morrison, SJ (2005). Cancer stem cells. Clin Adv Hematol Oncol 3: 171-172.
53. Giangreco, A, Groot, KR and Janes, SM (2007). Lung cancer and lung stem cells: strange bedfellows? Am J Respir Crit Care Med 175: 547-553. (Pubitemid 46438936)
54. Curtis, SJ, Sinkevicius, KW, Li, D, Lau, AN, Roach, RR, Zamponi, R et al. (2010). Primary tumor genotype is an important determinant in identification of lung cancer propagating cells. Cell Stem Cell 7: 127-133.
55. Ho, MM, Ng, AV, Lam, S and Hung, JY (2007). Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67: 4827-4833. (Pubitemid 46910191)
56. Eramo, A, Lotti, F, Sette, G, Pilozzi, E, Biffoni, M, Di Virgilio, A et al. (2008). Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514. (Pubitemid 351267301)
57. Bertolini, G, Roz, L, Perego, P, Tortoreto, M, Fontanella, E, Gatti, L et al. (2009). Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA 106: 16281-16286.
58. Tirino, V, Camerlingo, R, Franco, R, Malanga, D, La Rocca, A, Viglietto, G et al. (2009). The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer. Eur J Cardiothorac Surg 36: 446-453.
59. Beier, D, Hau, P, Proescholdt, M, Lohmeier, A, Wischhusen, J, Oefner, PJ et al. (2007). CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015. (Pubitemid 46815044)
60. Shmelkov, SV, Butler, JM, Hooper, AT, Hormigo, A, Kushner, J, Milde, T et al. (2008). CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120. (Pubitemid 351872330)
61. Quintana, E, Shackleton, M, Sabel, MS, Fullen, DR, Johnson, TM and Morrison, SJ (2008). Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
62. Meng, X, Li, M, Wang, X, Wang, Y and Ma, D (2009). Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci 100: 1040-1046.
63. Cui, F, Wang, J, Chen, D and Chen, YJ (2011). CD133 is a temporary marker of cancer stem cells in small cell lung cancer, but not in non-small cell lung cancer. Oncol Rep 25: 701-708.
64. Leung, EL, Fiscus, RR, Tung, JW, Tin, VP, Cheng, LC, Sihoe, AD et al. (2010). Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS ONE 5: e14062.
65. Jiang, F, Qiu, Q, Khanna, A, Todd, NW, Deepak, J, Xing, L et al. (2009). Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7: 330-338.
66. Sullivan, JP, Spinola, M, Dodge, M, Raso, MG, Behrens, C, Gao, B et al. (2010). Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 70: 9937-9948.
67. Liang, D and Shi, Y (2011). Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma. Med Oncol 28: 315-321.
68. Swenson, ES, Price, JG, Brazelton, T and Krause, DS (2007). Limitations of green fluorescent protein as a cell lineage marker. Stem Cells 25: 2593-2600. (Pubitemid 47582752)
69. Beckett, T, Loi, R, Prenovitz, R, Poynter, M, Goncz, KK, Suratt, BT et al. (2005). Acute lung injury with endotoxin or NO2 does not enhance development of airway epithelium from bone marrow. Mol Ther 12: 680-686. (Pubitemid 41350149)
70. Loi, R, Beckett, T, Goncz, KK, Suratt, BT and Weiss, DJ (2006). Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. Am J Respir Crit Care Med 173: 171-179. (Pubitemid 43187889)
71. Sueblinvong, V, Loi, R, Eisenhauer, PL, Bernstein, IM, Suratt, BT, Spees, JL et al. (2008). Derivation of lung epithelium from human cord blood-derived mesenchymal stemcells. Am J Respir Crit Care Med 177: 701-711. (Pubitemid 351490557)
72. Kotton, DN, Fabian, AJ and Mulligan, RC (2005). Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 33: 328-334. (Pubitemid 41416282)
73. Chang, JC, Summer, R, Sun, X, Fitzsimmons, K and Fine, A (2005). Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am J Respir Cell Mol Biol 33: 335-342. (Pubitemid 41416283)
74. Takahashi, M, Nakamura, T, Toba, T, Kajiwara, N, Kato, H and Shimizu, Y (2004). Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 10: 771-779. (Pubitemid 38880395)
75. Zhao, YD, Courtman, DW, Deng, Y, Kugathasan, L, Zhang, Q and Stewart, DJ (2005). Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 96: 442-450. (Pubitemid 40354538)
76. Raoul, W, Wagner-Ballon, O, Saber, G, Hulin, A, Marcos, E, Giraudier, S et al. (2007). Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. Respir Res 8: 8.
77. Lam, CF, Liu, YC, Hsu, JK, Yeh, PA, Su, TY, Huang, CC et al. (2008). Autologous transplantation of endothelial progenitor cells attenuates acute lung injury in rabbits. Anesthesiology 108: 392-401.
78. Yoshida, H, Kitaichi, T, Urata, M, Kurobe, H, Kanbara, T, Motoki, T et al. (2009). Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation. Ann Thorac Surg 88: 418-424.
79. Wang, XX, Zhang, FR, Shang, YP, Zhu, JH, Xie, XD, Tao, QM et al. (2007). Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 49: 1566-1571.
80. Zhu, JH, Wang, XX, Zhang, FR, Shang, YP, Tao, QM, Zhu, JH et al. (2008). Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study. Pediatr Transplant 12: 650-655.
81. Phinney, DG and Prockop, DJ (2007). Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 25: 2896-2902. (Pubitemid 350127874)
82. Nauta, AJ and Fibbe, WE (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood 110: 3499-3506. (Pubitemid 350159613)
83. Prockop, DJ (2009). Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther 17: 939-946.
84. Giordano, A, Galderisi, U and Marino, IR (2007). From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol 211: 27-35. (Pubitemid 46363893)
85. Uccelli, A, Moretta, L and Pistoia, V (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
86. Dominici, M, Le Blanc, K, Mueller, I, Slaper-Cortenbach, I, Marini, F, Krause, D et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells.The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. (Pubitemid 44269669)
87. Le Blanc, K, Rasmusson, I, Sundberg, B, Götherström, C, Hassan, M, Uzunel, Met al. (2004). Treatment of severe acute graft-versus-host disease with third partyhaploidentical mesenchymal stem cells. Lancet 363: 1439-1441. (Pubitemid 38586721)
88. Ringdén, O, Uzunel, M, Rasmusson, I, Remberger, M, Sundberg, B, Lönnies, H et al. (2006). Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81: 1390-1397. (Pubitemid 43847148)
89. Fang, B, Song, YP, Liao, LM, Han, Q and Zhao, RC (2006). Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 38: 389-390.
90. Hare, JM, Traverse, JH, Henry, TD, Dib, N, Strumpf, RK, Schulman, SP et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54: 2277-2286.
91. Ortiz, LA, Gambelli, F, McBride, C, Gaupp, D, Baddoo, M, Kaminski, N et al. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100: 8407-8411. (Pubitemid 36842558)
92. Ortiz, LA, Dutreil, M, Fattman, C, Pandey, AC, Torres, G, Go, K et al. (2007). Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007. (Pubitemid 47175216)
93. Zhao, F, Zhang, YF, Liu, YG, Zhou, JJ, Li, ZK, Wu, CG et al. (2008). Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc 40: 1700-1705. (Pubitemid 351853229)
94. Moodley, Y, Atienza, D, Manuelpillai, U, Samuel, CS, Tchongue, J, Ilancheran, S et al. (2009). Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycininduced lung injury. Am J Pathol 175: 303-313.
95. Germano, D, Blyszczuk, P, Valaperti, A, Kania, G, Dirnhofer, S, Landmesser, U et al. (2009). Prominin-1/CD133+ lung epithelial progenitors protect from bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med 179: 939-949.
96. Aguilar, S, Scotton, CJ, McNulty, K, Nye, E, Stamp, G, Laurent, G et al. (2009). Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS ONE 4: e8013.
97. Kumamoto, M, Nishiwaki, T, Matsuo, N, Kimura, H and Matsushima, K (2009). Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 34: 740-748.
98. Cargnoni, A, Gibelli, L, Tosini, A, Signoroni, PB, Nassuato, C, Arienti, D et al. (2009). Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18: 405-422.
99. Lee, SH, Jang, AS, Kim, YE, Cha, JY, Kim, TH, Jung, S et al. (2010). Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir Res 11: 16.
100. Mei, SH, McCarter, SD, Deng, Y, Parker, CH, Liles, WC and Stewart, DJ (2007). Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4: e269.
101. Xu, J, Qu, J, Cao, L, Sai, Y, Chen, C, He, L et al. (2008). Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice. J Pathol 214: 472-481. (Pubitemid 351340567)
102. Gupta, N, Su, X, Popov, B, Lee, JW, Serikov, V and Matthay, MA (2007). Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863.
103. Xu, J, Woods, CR, Mora, AL, Joodi, R, Brigham, KL, Iyer, S et al. (2007). Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293: L131-L141. (Pubitemid 47080721)
104. Fang, X, Neyrinck, AP, Matthay, MA and Lee, JW (2010). Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 285: 26211-26222.
105. Lee, JW, Fang, X, Gupta, N, Serikov, V and Matthay, MA (2009). Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106: 16357-16362.
106. Németh, K, Leelahavanichkul, A, Yuen, PS, Mayer, B, Parmelee, A, Doi, K et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
107. Gonzalez-Rey, E, Anderson, P, González, MA, Rico, L, Bücher, D and Delgado, M (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58: 929-939.
108. Mei, SH, Haitsma, JJ, Dos Santos, CC, Deng, Y, Lai, PF, Slutsky, AS et al. (2010). Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 182: 1047-1057.
109. Yagi, H, Soto-Gutierrez, A, Kitagawa, Y, Tilles, AW, Tompkins, RG and Yarmush, ML (2010). Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant 19: 823-830.
110. Yagi, H, Soto-Gutierrez, A, Navarro-Alvarez, N, Nahmias, Y, Goldwasser, Y, Kitagawa, Y et al. (2010). Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18: 1857-1864.
111. Krasnodembskaya, A, Song, Y, Fang, X, Gupta, N, Serikov, V, Lee, JW et al. (2010). Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 28: 2229-2238.
112. Manning, E, Pham, S, Li, S, Vazquez-Padron, RI, Mathew, J, Ruiz, P et al. (2010). Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 21: 713-727.
113. Yang, Z, Sharma, AK, Marshall, M, Kron, IL and Laubach, VE (2009). NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. Am J Respir Cell Mol Biol 40: 375-381.
114. Baber, SR, Deng, W, Master, RG, Bunnell, BA, Taylor, BK, Murthy, SN et al. (2007). Intratracheal mesenchymal stem cell administration attenuates monocrotalineinduced pulmonary hypertension and endothelial dysfunction. Am J Physiol Heart Circ Physiol 292: H1120-H1128.
115. Umar, S, de Visser, YP, Steendijk, P, Schutte, CI, Laghmani, el H, Wagenaar, GT et al. (2009). Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. Am J Physiol Heart Circ Physiol 297: H1606-H1616.
116. Kanki-Horimoto, S, Horimoto, H, Mieno, S, Kishida, K, Watanabe, F, Furuya, E et al. (2006). Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension. Circulation 114(1 Suppl): I181-I185. (Pubitemid 44297148)
117. van Haaften, T, Byrne, R, Bonnet, S, Rochefort, GY, Akabutu, J, Bouchentouf, M et al. (2009). Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 180: 1131-1142.
118. Aslam, M, Baveja, R, Liang, OD, Fernandez-Gonzalez, A, Lee, C, Mitsialis, SA et al. (2009). Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130.
119. Chang, YS, Oh, W, Choi, SJ, Sung, DK, Kim, SY, Choi, EY et al. (2009). Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 18: 869-886.
120. Cho, KS, Park, HK, Park, HY, Jung, JS, Jeon, SG, Kim, YK et al. (2009). IFATS collection: Immunomodulatory effects of adipose tissue-derived stem cells in an allergic rhinitis mouse model. Stem Cells 27: 259-265.
121. Park, HK, Cho, KS, Park, HY, Shin, DH, Kim, YK, Jung, JS et al. (2010). Adiposederived stromal cells inhibit allergic airway inflammation in mice. Stem Cells Dev 19: 1811-1818.
122. Nemeth, K, Keane-Myers, A, Brown, JM, Metcalfe, DD, Gorham, JD, Gorham, JD et al. (2010). Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proc Natl Acad Sci USA 107: 5652-5657.
123. Bonfield, TL, Koloze, M, Lennon, DP, Zuchowski, B, Yang, SE and Caplan, AI (2010). Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 299: L760-L770.
124. Goodwin, M, Sueblinvong, V, Eisenhauer, P, Ziats, NP, LeClair, L, Poynter, ME et al. (2011). Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 29: 1137-1148.
125. Jang, HJ, Cho, KS, Park, HY and Roh, HJ (2011). Adipose tissue-derived stem cells for cell therapy of airway allergic diseases in mouse. Acta Histochemica 113: 501-507.
126. Ishizawa, K, Kubo, H, Yamada, M, Kobayashi, S, Numasaki, M, Ueda, S et al. (2004). Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett 556: 249-252. (Pubitemid 38058587)
127. Shigemura, N, Okumura, M, Mizuno, S, Imanishi, Y, Nakamura, T and Sawa, Y (2006). Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant 6: 2592-2600. (Pubitemid 44571679)
128. Shigemura, N, Okumura, M, Mizuno, S, Imanishi, Y, Matsuyama, A, Shiono, H et al. (2006). Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. Am J Respir Crit Care Med 174: 1199-1205. (Pubitemid 44924820)
129. Yuhgetsu, H, Ohno, Y, Funaguchi, N, Asai, T, Sawada, M, Takemura, G et al. (2006). Beneficial effects of autologous bone marrow mononuclear cell transplantation against elastase-induced emphysema in rabbits. Exp Lung Res 32: 413-426. (Pubitemid 44949859)
130. Adachi, Y, Oyaizu, H, Taketani, S, Minamino, K, Yamaguchi, K, Shultz, LD et al. (2006). Treatment and transfer of emphysema by a new bone marrow transplantation method from normal mice to Tsk mice and vice versa. Stem Cells 24: 2071-2077. (Pubitemid 44477132)
131. Zhen, G, Liu, H, Gu, N, Zhang, H, Xu, Y and Zhang, Z (2008). Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci 13: 3415-3422. (Pubitemid 351594692)
132. Schweitzer, KS, Johnstone, BH, Garrison, J, Rush, NI, Cooper, S, Traktuev, DO et al. (2011). Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 183: 215-225.
133. Katsha, AM, Ohkouchi, S, Xin, H, Kanehira, M, Sun, R, Nukiwa, T et al. (2011). Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 19: 196-203.
134. Zhen, G, Xue, Z, Zhao, J, Gu, N, Tang, Z, Xu, Y et al. (2010). Mesenchymal stem cell transplantation increases expression of vascular endothelial growth factor in papain-induced emphysematous lungs and inhibits apoptosis of lung cells. Cytotherapy 12: 605-614.
135. 〈http://investor.osiris.com/releasedetail.cfm?ReleaseID= 311598〉.
136. Grove, DA, Xu, J, Joodi, R, Torres-Gonzales, E, Neujahr, D, Mora, AL et al. (2011). Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation. J Heart Lung Transplant 30: 341-350.
137. Direkze, NC, Hodivala-Dilke, K, Jeffery, R, Hunt, T, Poulsom, R, Oukrif, D et al. (2004). Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64: 8492-8495. (Pubitemid 39552057)
138. Hilbe, W, Dirnhofer, S, Oberwasserlechner, F, Schmid, T, Gunsilius, E, Hilbe, G et al. (2004). CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57: 965-969. (Pubitemid 39208249)
139. Studeny, M, Marini, FC, Dembinski, JL, Zompetta, C, Cabreira-Hansen, M, Bekele, BN et al. (2004). Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96: 1593-1603. (Pubitemid 39534883)
140. Gao, D, Nolan, DJ, Mellick, AS, Bambino, K, McDonnell, K and Mittal, V (2008). Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198.
141. Arap, W and Pasqualini, R (2004). Engineered embryonic endothelial progenitor cells as therapeutic Trojan horses. Cancer Cell 5: 406-408. (Pubitemid 38610241)
142. Loebinger, MR and Janes, SM (2010). Stem cells as vectors for antitumour therapy. Thorax 65: 362-369.
143. Studeny, M, Marini, FC, Dembinski, JL, Zompetta, C, Cabreira-Hansen, M,Bekele, BN et al. (2004). Mesenchymal stem cells: potential precursors for tumorstroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96:1593-1603. (Pubitemid 39534883)
144. Wei, J, Blum, S, Unger, M, Jarmy, G, Lamparter, M, Geishauser, A et al. (2004).Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lungmetastases after intravenous delivery. Cancer Cell 5: 477-488. (Pubitemid 38610249)
145. Hall, B, Dembinski, J, Sasser, AK, Studeny, M, Andreeff, M and Marini, F (2007). Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 86: 8-16. (Pubitemid 47204483)
146. Kanehira, M, Xin, H, Hoshino, K, Maemondo, M, Mizuguchi, H, Hayakawa, T et al. (2007). Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. Cancer Gene Ther 14: 894-903. (Pubitemid 47557220)
147. Rachakatla, RS, Marini, F, Weiss, ML, Tamura, M and Troyer, D (2007). Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther 14: 828-835. (Pubitemid 47402382)
148. Stoff-Khalili, MA, Rivera, AA, Mathis, JM, Banerjee, NS, Moon, AS, Hess, A et al. (2007). Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat 105: 157-167. (Pubitemid 47366887)
149. Xin, H, Kanehira, M, Mizuguchi, H, Hayakawa, T, Kikuchi, T, Nukiwa, T et al. (2007). Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 25: 1618-1626. (Pubitemid 47121838)
150. Zhang, X, Zhao, P, Kennedy, C, Chen, K, Wiegand, J, Washington, G et al. (2008). Treatment of pulmonary metastatic tumors in mice using lentiviral vector-engineered stem cells. Cancer Gene Ther 15: 73-84.
151. Loebinger, MR, Kyrtatos, PG, Turmaine, M, Price, AN, Pankhurst, Q, Lythgoe, MF et al. (2009). Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 69: 8862-8867.
152. Loebinger, MR, Eddaoudi, A, Davies, D and Janes, SM (2009). Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 69: 4134-4142.
153. Matsuzuka, T, Rachakatla, RS, Doi, C, Maurya, DK, Ohta, N, Kawabata, A et al. (2010). Human umbilical cord matrix-derived stem cells expressing interferon-beta gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice. Lung Cancer 70: 28-36.
154. Prockop, DJ and Olson, SD (2007). Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions. Blood 109: 3147-3151. (Pubitemid 46572498)
155. Rameshwar, P (2009). Casting doubt on the safety of "off-the- shelf" mesenchymal stem cells for cell therapy. Mol Ther 17: 216-218.
156. Prockop, DJ, Brenner, M, Fibbe, WE, Horwitz, E, Le Blanc, K, Phinney, DG et al. (2010). Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12: 576-578.
157. Mishra, PJ, Mishra, PJ, Glod, JW and Banerjee, D (2009). Mesenchymal stem cells: flip side of the coin. Cancer Res 69: 1255-1258.
158. Aguilar, S, Nye, E, Chan, J, Loebinger, M, Spencer-Dene, B, Fisk, N et al. (2007). Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 25: 1586-1594. (Pubitemid 47106029)
159. Tolar, J, Nauta, AJ, Osborn, MJ, Panoskaltsis Mortari, A, McElmurry, RT, Bell, S et al. (2007). Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25: 371-379. (Pubitemid 46232791)
160. Bernardo, ME, Zaffaroni, N, Novara, F, Cometa, AM, Avanzini, MA, Moretta, A et al. (2007). Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67: 9142-9149. (Pubitemid 47535900)
161. Qin, Y, Ji, H, Wu, Y and Liu, H (2009). Chromosomal instability of murine adipose tissue-derived mesenchymal stem cells in long-term culture and development of cloned embryos. Cloning Stem Cells 11: 445-452.
162. Tarte, K, Gaillard, J, Lataillade, JJ, Fouillard, L, Becker, M, Mossafa, H et al.; Société Française de Greffe de Moelle et Thérapie Cellulaire. (2010). Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115: 1549-1553.
163. Rubio, D, Garcia, S, Paz, MF, De la Cueva, T, Lopez-Fernandez, LA, Lloyd, AC et al. (2008). Molecular characterization of spontaneous mesenchymal stem cell transformation. PLoS ONE 3: e1398.
164. Rubio, D, Garcia-Castro, J, Martín MC, de la Fuente, R, Cigudosa, JC, Lloyd, AC et al. (2005). Spontaneous human adult stem cell transformation. Cancer Res 65: 3035-3039. (Pubitemid 40524580)
165. Røsland, GV, Svendsen, A, Torsvik, A, Sobala, E, McCormack, E, Immervoll, H et al. (2009). Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69: 5331-5339.
166. Torsvik, A, Røsland, GV, Svendsen, A, Molven, A, Immervoll, H, McCormack, E et al. (2010). Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res 70: 6393-6396.
167. Weiss, DJ and Finck, C (2010). Embryonic stem cells and repair of lung injury. Mol Ther 18: 460-461.
168. Van Vranken, BE, Romanska, HM, Polak, JM, Rippon, HJ, Shannon, JM and Bishop, AE (2005). Coculture of embryonic stem cells with pulmonary mesenchyme: a microenvironment that promotes differentiation of pulmonary epithelium. Tissue Eng 11: 1177-1187. (Pubitemid 41321421)
169. Samadikuchaksaraei, A and Bishop, AE (2006). Derivation and characterization of alveolar epithelial cells from murine embryonic stem cells in vitro. Methods Mol Biol 330: 233-248.
170. Rippon, HJ, Polak, JM, Qin, M and Bishop, AE (2006). Derivation of distal lung epithelial progenitors from murine embryonic stem cells using a novel three-step differentiation protocol. Stem Cells 24: 1389-1398. (Pubitemid 44464707)
171. Denham, M, Cole, TJ and Mollard, R (2006). Embryonic stem cells form glandular structures and express surfactant protein C following culture with dissociated fetal respiratory tissue. Am J Physiol Lung Cell Mol Physiol 290: L1210-L1215. (Pubitemid 43830866)
172. Samadikuchaksaraei, A, Cohen, S, Isaac, K, Rippon, HJ, Polak, JM, Bielby, RC et al. (2006). Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng 12: 867-875. (Pubitemid 43726528)
173. Wang, D, Haviland, DL, Burns, AR, Zsigmond, E and Wetsel, RA (2007). A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 104: 4449-4454. (Pubitemid 47186246)
174. Van Vranken, BE, Rippon, HJ, Samadikuchaksaraei, A, Trounson, AO and Bishop, AE (2007). The differentiation of distal lung epithelium from embryonic stem cells. Curr Protoc Stem Cell Biol Chapter 1: Unit 1G.1.
175. Winkler, ME, Mauritz, C, Groos, S, Kispert, A, Menke, S, Hoffmann, A et al. (2008). Serum-free differentiation of murine embryonic stem cells into alveolar type II epithelial cells. Cloning Stem Cells 10: 49-64. (Pubitemid 351341553)
176. Roszell, B, Mondrinos, MJ, Seaton, A, Simons, DM, Koutzaki, SH, Fong, GH et al. (2009). Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application. Tissue Eng 15: 3351-3365.
177. Coraux, C, Nawrocki-Raby, B, Hinnrasky, J, Kileztky, C, Gaillard, D, Dani, C et al. (2005). Embryonic stem cells generate airway epithelial tissue. Am J Respir Cell Mol Biol 32: 87-92. (Pubitemid 40189689)
178. Van Haute, L, De Block, G, Liebaers, I, Sermon, K and De Rycke, M (2009). Generation of lung epithelial-like tissue from human embryonic stem cells. Respir Res 10: 105.
179. Wang, Y, Wong, LB and Mao, H (2010). Induction of ciliated cells from avian embryonic stem cells using three-dimensional matrix. Tissue Eng Part C Methods 16: 929-936.
180. Salminen, A, Paananen, R, Karjalainen, MK, Tuohimaa, A, Luukkonen, A, Ojaniemi, M et al. (2009). Genetic association of SP-C with duration of preterm premature rupture of fetal membranes and expression in gestational tissues. Ann Med 41: 629-642.
181. Mason, RJ and Williams, MC (1980). Phospholipid composition and ultrastructure of A549 cells and other cultured pulmonary epithelial cells of presumed type II cell origin. Biochim Biophys Acta 617: 36-50. (Pubitemid 10185881)
182. Spence, JR, Mayhew, CN, Rankin, SA, Kuhar, MF, Vallance, JE, Tolle, K et al. (2011). Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470: 105-109.
183. Wang, D, Morales, JE, Calame, DG, Alcorn, JL and Wetsel, RA (2010). Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther 18: 625-634.
184. Pickering, SJ, Minger, SL, Patel, M, Taylor, H, Black, C, Burns, CJ et al. (2005). Generation of a human embryonic stem cell line encoding the cystic fibrosis mutation deltaF508, using preimplantation genetic diagnosis. Reprod Biomed Online 10: 390-397. (Pubitemid 40372676)
185. Mateizel, I, De Temmerman, N, Ullmann, U, Cauffman, G, Sermon, K, Van de Velde, H et al. (2006). Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21: 503-511. (Pubitemid 43159929)
186. Deleu, S, Gonzalez-Merino, E, Gaspard, N, Nguyen, TM, Vanderhaeghen, P, Lagneaux, L et al. (2009). Human cystic fibrosis embryonic stem cell lines derived on placental mesenchymal stromal cells. Reprod Biomed Online 18: 704-716.
187. Sommer, CA, Stadtfeld, M, Murphy, GJ, Hochedlinger, K, Kotton, DN and Mostoslavsky, G (2009). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27: 543-549.
188. Somers, A, Jean, JC, Sommer, CA, Omari, A, Ford, CC, Mills, JA et al. (2010). Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28: 1728-1740.
189. Kunisaki, SM, Fuchs, JR, Steigman, SA and Fauza, DO (2007). A comparative analysis of cartilage engineered from different perinatal mesenchymal progenitor cells. Tissue Eng 13: 2633-2644. (Pubitemid 350076747)
190. Kunisaki, SM, Armant, M, Kao, GS, Stevenson, K, Kim, H and Fauza, DO (2007). Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. JPediatr Surg 42: 974-979; discussion 979-980.
191. Kunisaki, SM, Jennings, RW and Fauza, DO (2006). Fetal cartilage engineering from amniotic mesenchymal progenitor cells. Stem Cells Dev 15: 245-253. (Pubitemid 43726502)
192. Kunisaki, SM, Freedman, DA and Fauza, DO (2006). Fetal tracheal reconstruction with cartilaginous grafts engineered from mesenchymal amniocytes. J Pediatr Surg 41: 675-682; discussion 675-682.
193. Fuchs, JR, Hannouche, D, Terada, S, Zand, S, Vacanti, JP and Fauza, DO (2005). Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells 23: 958-964. (Pubitemid 41170951)
194. Kojima, K, Ignotz, RA, Kushibiki, T, Tinsley, KW, Tabata, Y and Vacanti, CA (2004). Tissue-engineered trachea from sheep marrow stromal cells with transforming growth factor beta2 released from biodegradable microspheres in a nude rat recipient. J Thorac Cardiovasc Surg 128: 147-153. (Pubitemid 38881209)
195. Omori, K, Nakamura, T, Kanemaru, S, Magrufov, A, Yamashita, M and Shimizu, Y (2008). In situ tissue engineering of the cricoid and trachea in a canine model. Ann Otol Rhinol Laryngol 117: 609-613.
196. Omori, K, Tada, Y, Suzuki, T, Nomoto, Y, Matsuzuka, T, Kobayashi, K et al. (2008). Clinical application of in situ tissue engineering using a scaffolding technique for reconstruction of the larynx and trachea. Ann Otol Rhinol Laryngol 117: 673-678.
197. Gilbert, TW, Gilbert, S, Madden, M, Reynolds, SD and Badylak, SF (2008). Morphologic assessment of extracellular matrix scaffolds for patch tracheoplasty in a canine model. Ann Thorac Surg 86: 967-74; discussion 967.
198. Jungebluth, P, Alici, E, Baiguera, S, Le Blanc, K, Blomberg, P, Bozóky, B et al. (2011). Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 378: 1997-2004.
199. Kunisaki, SM, Fuchs, JR, Kaviani, A, Oh, JT, LaVan, DA, Vacanti, JP et al. (2006). Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg 41: 34-9; discussion 34.
200. Fuchs, JR, Kaviani, A, Oh, JT, LaVan, D, Udagawa, T, Jennings, RW et al. (2004). Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg 39: 834-838; discussion 834-838.
201. Urita, Y, Komuro, H, Chen, G, Shinya, M, Saihara, R and Kaneko, M (2008). Evaluation of diaphragmatic hernia repair using PLGA mesh-collagen sponge hybrid scaffold: an experimental study in a rat model. Pediatr Surg Int 24: 1041-1045.
202. Cortiella, J, Nichols, JE, Kojima, K, Bonassar, LJ, Dargon, P, Roy, AK et al. (2006). Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng 12: 1213-1225. (Pubitemid 44024492)
203. Ingenito, EP, Sen, E, Tsai, LW, Murthy, S and Hoffman, A (2010). Design and testing ofbiological scaffolds for delivering reparative cells to target sites in the lung. J Tissue EngRegen Med 4: 259-272.
204. Mondrinos, MJ, Koutzaki, S, Lelkes, PI and Finck, CM (2007). A tissue-engineeredmodel of fetal distal lung tissue. Am J Physiol Lung Cell Mol Physiol 293: L639-L650. (Pubitemid 47358826)
205. Mondrinos, MJ, Koutzaki, S, Jiwanmall, E, Li, M, Dechadarevian, JP, Lelkes, PI et al. (2006). Engineering three-dimensional pulmonary tissue constructs. Tissue Eng 12: 717-728. (Pubitemid 43726516)
206. Lin, YM, Boccaccini, AR, Polak, JM, Bishop, AE and Maquet, V (2006). Biocompatibility of poly-DL-lactic acid (PDLLA) for lung tissue engineering. J Biomater Appl 21: 109-118. (Pubitemid 44848510)
207. Choe, MM, Sporn, PH and Swartz, MA (2006). Extracellular matrix remodeling by dynamic strain in a three-dimensional tissue-engineered human airway wall model. Am J Respir Cell Mol Biol 35: 306-313. (Pubitemid 44353398)
208. Liu, M, Xu, J, Souza, P, Tanswell, B, Tanswell, AK and Post, M (1995). The effect of mechanical strain on fetal rat lung cell proliferation: comparison of two- and three-dimensional culture systems. In Vitro Cell Dev Biol Anim 31: 858-866. (Pubitemid 26020406)
209. Liu, M, Tanswell, AK and Post, M (1999). Mechanical force-induced signal transduction in lung cells. Am J Physiol 277(4 Pt 1): L667-L683. (Pubitemid 29522632)
210. Liu, M and Post, M (2000). Invited review: mechanochemical signal transduction in the fetal lung. J Appl Physiol 89: 2078-2084.
211. Andrade, CF, Wong, AP, Waddell, TK, Keshavjee, S and Liu, M (2007). Cell-based tissue engineering for lung regeneration. Am J Physiol Lung Cell Mol Physiol 292: L510-L518.
212. Hoganson, DM, Pryor, HI 2nd and Vacanti, JP (2008). Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr Res 63: 520-526. (Pubitemid 351572222)
213. Mondrinos, MJ, Koutzaki, SH, Poblete, HM, Crisanti, MC, Lelkes, PI and Finck, CM (2008). In vivo pulmonary tissue engineering: contribution of donor-derived endothelial cells to construct vascularization. Tissue Eng Part A 14: 361-368.
214. Carterson, AJ, Höner zu Bentrup, K, Ott, CM, Clarke, MS, Pierson, DL, Vanderburg, CR et al. (2005). A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis. Infect Immun 73: 1129-1140.
215. Crabbé A, De Boever, P, Van Houdt, R, Moors, H, Mergeay, M and Cornelis, P (2008). Use of the rotating wall vessel technology to study the effect of shear stress on growth behaviour of Pseudomonas aeruginosa PA01. Environ Microbiol 10: 2098-2110.
216. Rothen-Rutishauser, BM, Kiama, SG and Gehr, P (2005). A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 32: 281-289. (Pubitemid 40478303)
217. Huh, D, Matthews, BD, Mammoto, A, Montoya-Zavala, M, Hsin, HY and Ingber, DE (2010). Reconstituting organ-level lung functions on a chip. Science 328: 1662-1668.
218. Panoskaltsis-Mortari, A and Weiss, DJ (2010). Breathing new life into lung transplantation therapy. Mol Ther 18: 1581-1583.
219. Lwebuga-Mukasa, JS, Ingbar, DH and Madri, JA (1986). Repopulation of a human alveolar matrix by adult rat type II pneumocytes in vitro. A novel system for type II pneumocyte culture. Exp Cell Res 162: 423-435. (Pubitemid 16131242)
220. Antunes, MB, Woodworth, BA, Bhargave, G, Xiong, G, Aguilar, JL, Ratner, AJ et al. (2007). Murine nasal septa for respiratory epithelial air-liquid interface cultures. BioTechniques 43: 195-196, 198, 200 passim.
221. Price, AP, England, KA, Matson, AM, Blazar, BR and Panoskaltsis-Mortari, A (2010). Development of a decellularized lung bioreactor system for bioengineering the lung: the matrix reloaded. Tissue Eng Part A 16: 2581-2591.
222. Cortiella, J, Niles, J, Cantu, A, Brettler, A, Pham, A, Vargas, G et al. (2010). Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 16: 2565-2580.
223. Petersen, TH, Calle, EA, Zhao, L, Lee, EJ, Gui, L, Raredon, MB et al. (2010). Tissue-engineered lungs for in vivo implantation. Science 329: 538-541.
224. Ott, HC, Clippinger, B, Conrad, C, Schuetz, C, Pomerantseva, I, Ikonomou, L et al. (2010). Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 16: 927-933.
225. Daly, AB, Wallis, JM, Borg, ZD, Bonvillain, RW, Deng, B, Ballif, BA et al. (2012). Initial binding and re-cellularization of de-cellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A 18: 1-16.
226. Wallis, JM, Borg, ZD, Daly, AB, Deng, B, Ballif, BA, Allen, GB et al. (2012). Comparative Assessment of Detergent-Based Protocols for Mouse Lung De-Cellularization and Re- Cellularization. Tissue Eng Part C Methods (epub ahead of print).
227. Song, JJ, Kim, SS, Liu, Z, Madsen, JC, Mathisen, DJ, Vacanti, JP et al. (2011). Enhanced in vivo function of bioartificial lungs in rats. Ann Thorac Surg 92: 998-1005; discussion 1005-1006.
228. Randell, SH (2006). Airway epithelial stem cells and the pathophysiology of chronic obstructive pulmonary disease. Proc Am Thorac Soc 3: 718-725.
229. Stripp, BR, Maxson, K, Mera, R and Singh, G (1995). Plasticity of airway cellproliferation and gene expression after acute naphthalene injury. Am J Physiol 269(6 Pt 1): L791-L799. (Pubitemid 26021924)
230. Sueblinvong, V and Weiss, DJ (2010). Stem cells and cell therapy approaches in lung biology and diseases. Transl Res 156: 188-205.